Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Prognostic Significance of Genomic Alterations in Mantle Cell Lymphoma

Anita Kumar, MD, Wendy Yang, MD, Kurt S Bantilan, MPH, Michael Berger, PhD, Nikolaus Schultz, PhD, Connie Batlevi, MD PhD, Andrew D. Zelenetz

Blood (2016) 128 (22): 4115.

https://doi.org/10.1182/blood.V128.22.4115.4115

Published: 2016

Journal Articles

Mutational Analysis of Clonal Hematopoiesis in Solid Tumor Patients Illustrates the Critical Role of Systemic Anti-Cancer Therapies in the Evolution of Somatic Leukemia Disease Alleles

Catherine C. Coombs, MD, Ahmet Zehir, PhD, Sean Devlin, PhD, Ashwin Kishtagari, MD, David M. Hyman, David Solit, MD, Mark Robson, MD, Jose Baselga, MD PhD, Maria Arcila, MD, Martin S. Tallman, MD, Ross L. Levine, MD, Michael Berger, PhD

Blood (2016) 128 (22): 37.

https://doi.org/10.1182/blood.V128.22.37.37

Published: 2016

Journal Articles

Next-Generation Sequencing of Matched Normal Blood Identifies Clonal Hematopoiesis in a Significant Subset of Solid Tumor Patients without Hematologic Malignancies

Catherine C. Coombs, MD, Ahmet Zehir, PhD, Sean Devlin, PhD, Sumit Middha, PhD, Donavan Cheng, PhD, Ashwin Kishtagari, MD, David M. Hyman, David Solit, MD, Mark Robson, MD, Jose Baselga, MD PhD, Maria Arcila, MD, Mark Ladanyi, MD, Martin S Tallman, MD, Ross L. Levine, MD, Michael Berger, PhD

Blood (2015) 126 (23): 2447.

https://doi.org/10.1182/blood.V126.23.2447.2447

Published: 2015

Journal Articles

Diverse Mechanisms of Vemurafenib Resistance in BRAF-Mutant Hairy Cell Leukemia

Jae H Park, MD, Stephen S. Chung, MD, Benjamin Durham, MD PhD, Young Rock Chung, MS, Sasinya Scott, MPH, Bartlomiej Getta, MBBS,, Eunhee Kim, PhD, Alan Saven, MD, Richard M. Stone, MD, Kanti R Rai, MD, Michael R. Grever, MD, Jessica K. Altman, MD, Neal Rosen, MD PhD, Ross L. Levine, MD, Michael Berger, PhD, Martin S Tallman, MD, Omar Abdel-Wahab

Blood (2015) 126 (23): 449.

https://doi.org/10.1182/blood.V126.23.449.449

Published: 2015

Journal Articles

Distinctive Genomic Alterations in Testicular Diffuse Large B Cell Lymphoma

Connie Batlevi, MD PhD, Franck Rapaport, PhD, Lu Wang, MD PhD, Andrew M. Intlekofer, MD PhD, Amanda R. Copeland, RN, MSN, CNS, Achim A Jungbluth, MD, Anne Reiner, MPH, Janine D. Pichardo, BS, Meighan Gallagher, MA, Nancy Bouvier, BS, Nicholas D. Socci, PhD, Frederick Criscuolo, PhD, Nikolaus Schultz, PhD, Maria Arcila, MD, Michael Berger, PhD, Andrew D Zelenetz, MD PhD, Venkatraman E Seshan, PhD, Ahmet Dogan, MD PhD, Anas Younes, MD

Blood (2015) 126 (23): 3655.

https://doi.org/10.1182/blood.V126.23.3655.3655

Published: 2015

Journal Articles

Vemurafenib Has Potent Antitumor Activity in Patients with Relapsed/Refractory BRAF Mutant Hairy Cell Leukemia

Jae H Park, MD, Stephen S. Chung, MD, Young Rock Chung, MS, Helen Won, MS, Eunhee Kim, PhD, Alan Saven, MD, Martha Wadleigh, MD, Richard M. Stone, MD, Jacqueline C. Barrientos, MD, Kanti R. Rai, MD, Michael R. Grever, MD, Jessica K. Altman, MD, Mario E Lacouture, MD, Neal Rosen, MD PhD, Michael Berger, PhD, Ross L Levine, MD, Omar Abdel-Wahab, MD, Martin S. Tallman, MD

Blood (2014) 124 (21): 24.

https://doi.org/10.1182/blood.V124.21.24.24

Published: 2014

Journal Articles

Phase II Trial Of The BRAF Inhibitor, Vemurafenib, In Patients With BRAF Mutant Relapsed Or Refractory Hairy Cell Leukemia

Jae H Park, MD, Stephen S. Chung, MD, Young Rock Chung, MSc, Helen Won, MS, Julie Teruya-Feldstein, MD, Michael Berger, PhD, Talal T Khawaja, BS, Mario E Lacouture, MD, Ross L. Levine, MD, Omar Abdel-Wahab, MD, Martin S Tallman, MD

Blood (2013) 122 (21): 2876.

https://doi.org/10.1182/blood.V122.21.2876.2876

Published: 2013

Journal Articles

Safety and immunologic effects of IL-15 administration in nonhuman primates

Carolina Berger, Michael Berger, Robert C. Hackman, Michael Gough, Carole Elliott, Michael C. Jensen, Stanley R. Riddell

Blood (2009) 114 (12): 2417–2426.

https://doi.org/10.1182/blood-2008-12-189266

Published: 2009

Includes: Supplemental data

Journal Articles

In Vivo Administration of Interleukin 15 (IL-15) Safely Promotes the Survival and Proliferation of Adoptively Transferred Antigen-Specific T Cell Clones

Carolina Berger, MD, Michael Berger, Michael C Jensen, MD, Stanley R Riddell, MD

Blood (2008) 112 (11): 679.

https://doi.org/10.1182/blood.V112.11.679.679

Published: 2008

NARROW

Prognostic Significance of Genomic Alterations in Mantle Cell Lymphoma

Mutational Analysis of Clonal Hematopoiesis in Solid Tumor Patients Illustrates the Critical Role of Systemic Anti-Cancer Therapies in the Evolution of Somatic Leukemia Disease Alleles

Next-Generation Sequencing of Matched Normal Blood Identifies Clonal Hematopoiesis in a Significant Subset of Solid Tumor Patients without Hematologic Malignancies

Diverse Mechanisms of Vemurafenib Resistance in BRAF-Mutant Hairy Cell Leukemia

Distinctive Genomic Alterations in Testicular Diffuse Large B Cell Lymphoma

Vemurafenib Has Potent Antitumor Activity in Patients with Relapsed/Refractory BRAF Mutant Hairy Cell Leukemia

Phase II Trial Of The BRAF Inhibitor, Vemurafenib, In Patients With BRAF Mutant Relapsed Or Refractory Hairy Cell Leukemia

Safety and immunologic effects of IL-15 administration in nonhuman primates

In Vivo Administration of Interleukin 15 (IL-15) Safely Promotes the Survival and Proliferation of Adoptively Transferred Antigen-Specific T Cell Clones

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only